{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:59:00Z","timestamp":1780876740918,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48836-1","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:51:24Z","timestamp":1776318684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Galectin-4 contributes to the maintenance of expression and activation of multiple receptor-type kinases involved in peritoneal metastasis"],"prefix":"10.1038","volume":"16","author":[{"given":"Hiroko","family":"Ideo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwa","family":"Umebayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"48836_CR1","first-page":"49","volume":"73","author":"JM Foster","year":"2023","unstructured":"Foster, J. M., Zhang, C., Rehman, S., Sharma, P. & Alexander, H. R. The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future. CA Cancer J. Clin 73, 49\u201371 (2023).","journal-title":"CA Cancer J. Clin"},{"key":"48836_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.20517\/2394-4722.2017.77","volume":"4","author":"Y Kiyozumi","year":"2018","unstructured":"Kiyozumi, Y. et al. Update on targeted therapy and immune therapy for gastric cancer. J. Cancer Metastasis Trea 4, 31 (2018).","journal-title":"J. Cancer Metastasis Trea"},{"key":"48836_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10585-016-9791-0","volume":"33","author":"N Sluiter","year":"2016","unstructured":"Sluiter, N. et al. Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options. Clin. Exp. Metastasis 33, 401\u2013416 (2016).","journal-title":"Clin. Exp. Metastasis"},{"key":"48836_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s13238-016-0262-9","volume":"7","author":"Z-Q Cao","year":"2016","unstructured":"Cao, Z.-Q. & Guo, X.-L. The role of galectin-4 in physiology and diseases. Protein Cell 7, 314\u2013324 (2016).","journal-title":"Protein Cell"},{"key":"48836_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/B:GLYC.0000025819.54723.a0","volume":"20","author":"ME Huflejt","year":"2004","unstructured":"Huflejt, M. E. & Leffler, H. Galectin-4 in normal tissues and cancer. Glycoconj J. 20, 247\u2013255 (2004).","journal-title":"Glycoconj J."},{"key":"48836_CR6","doi-asserted-by":"publisher","first-page":"5756","DOI":"10.1158\/0008-5472.CAN-16-0641","volume":"76","author":"C-H Tsai","year":"2016","unstructured":"Tsai, C.-H. et al. Metastatic progression of prostate cancer is mediated by autonomous binding of galectin-4-O-Glycan to cancer cells. Cancer Res. 76, 5756\u20135767 (2016).","journal-title":"Cancer Res."},{"key":"48836_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s10120-023-01366-5","volume":"26","author":"H Ideo","year":"2023","unstructured":"Ideo, H. et al. Suppression of galectin-4 attenuates peritoneal metastasis of poorly differentiated gastric cancer cells. Gastric Cancer 26, 352\u2013363 (2023).","journal-title":"Gastric Cancer"},{"key":"48836_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081883","volume":"8","author":"T Hayashi","year":"2013","unstructured":"Hayashi, T. et al. Galectin-4, a novel predictor for lymph node metastasis in lung adenocarcinoma. PLoS ONE 8, e81883 (2013).","journal-title":"PLoS ONE"},{"key":"48836_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1158\/2326-6066.CIR-21-1088","volume":"11","author":"T Lidstr\u00f6m","year":"2023","unstructured":"Lidstr\u00f6m, T. et al. Extracellular galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer. Cancer Immunol. Res. 11, 72\u201392 (2023).","journal-title":"Cancer Immunol. Res."},{"key":"48836_CR10","first-page":"11353","volume":"13","author":"A Acharjee","year":"2021","unstructured":"Acharjee, A. et al. Immune infiltration and prognostic and diagnostic use of LGALS4 in colon adenocarcinoma and bladder urothelial carcinoma. Am. J. Transl Res. 13, 11353\u201311363 (2021).","journal-title":"Am. J. Transl Res."},{"key":"48836_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ijc.25750","volume":"129","author":"A Satelli","year":"2011","unstructured":"Satelli, A., Rao, P. S., Thirumala, S. & Rao, U. S. Galectin-4 functions as a tumor suppressor of human colorectal cancer. Int. J. Cancer. 129, 799\u2013809 (2011).","journal-title":"Int. J. Cancer."},{"key":"48836_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091159","volume":"9","author":"C-H Li","year":"2021","unstructured":"Li, C.-H. et al. Galectins in cancer and the microenvironment: Functional roles, therapeutic developments, and perspectives. Biomedicines 9, 1159 (2021).","journal-title":"Biomedicines"},{"key":"48836_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwae064","volume":"34","author":"A Tsuchida","year":"2024","unstructured":"Tsuchida, A., Hachisu, K., Mizuno, M., Takada, Y. & Ideo, H. High expression of B3GALT5 suppresses the galectin-4-mediated peritoneal dissemination of poorly differentiated gastric cancer cells. Glycobiology 34, cwae064 (2024).","journal-title":"Glycobiology"},{"key":"48836_CR14","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1093\/glycob\/cwt073","volume":"23","author":"H Ideo","year":"2013","unstructured":"Ideo, H., Hoshi, I., Yamashita, K. & Sakamoto, M. Phosphorylation and externalization of galectin-4 is controlled by Src family kinases. Glycobiology 23, 1452\u20131462 (2013).","journal-title":"Glycobiology"},{"key":"48836_CR15","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1074\/jbc.M410362200","volume":"280","author":"H Ideo","year":"2005","unstructured":"Ideo, H., Seko, A. & Yamashita, K. Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J. Biol. Chem. 280, 4730\u20134737 (2005).","journal-title":"J. Biol. Chem."},{"key":"48836_CR16","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.208884","volume":"131","author":"L Johannes","year":"2018","unstructured":"Johannes, L., Jacob, R. & Leffler, H. Galectins at a glance. J. Cell Sci. 131, jcs208884 (2018).","journal-title":"J. Cell Sci."},{"key":"48836_CR17","doi-asserted-by":"publisher","first-page":"12542","DOI":"10.1074\/jbc.M413724200","volume":"280","author":"C Lingwood","year":"2005","unstructured":"Lingwood, C. et al. The sulfogalactose moiety of sulfoglycosphingolipids serves as a mimic of tyrosine phosphate in many recognition processes prediction and demonstration of Src homology 2 domain sulfogalactose bindin. J. Biol. Chem. 280, 12542 (2005).","journal-title":"J. Biol. Chem."},{"key":"48836_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-023-00636-2","volume":"22","author":"KV Mari\u00f1o","year":"2023","unstructured":"Mari\u00f1o, K. V., Cagnoni, A. J., Croci, D. O. & Rabinovich, G. A. Targeting galectin-driven regulatory circuits in cancer and fibrosis. Nat. Rev. Drug Discov. 22, 295\u2013316 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"48836_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1039\/D2CS00736C","volume":"52","author":"M Mart\u00ednez-Bail\u00e9n","year":"2023","unstructured":"Mart\u00ednez-Bail\u00e9n, M., Rojo, J. & Ramos-Soriano, J. Multivalent glycosystems for human lectins. Chem. Soc. Rev. 52, 536\u2013572 (2023).","journal-title":"Chem. Soc. Rev."},{"key":"48836_CR20","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.3390\/molecules28104039","volume":"28","author":"K Sl\u00e1mov\u00e1","year":"2023","unstructured":"Sl\u00e1mov\u00e1, K. et al. Oligosaccharide Ligands of Galectin-4 and Its Subunits: Multivalency Scores Highly. Molecules 28, 4039 (2023).","journal-title":"Molecules"},{"key":"48836_CR21","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/cas.12301","volume":"104","author":"L Zhao","year":"2013","unstructured":"Zhao, L. et al. Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer. Cancer Sci. 104, 1640\u20131646 (2013).","journal-title":"Cancer Sci."},{"key":"48836_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/biomedicines3010046","volume":"3","author":"G Viticchi\u00e8","year":"2015","unstructured":"Viticchi\u00e8, G. & Muller, P. A. J. c-Met and other cell surface molecules: Interaction, activation and functional consequences. Biomedicines 3, 46\u201370 (2015).","journal-title":"Biomedicines"},{"key":"48836_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1152\/physrev.00005.2011","volume":"92","author":"S Sigismund","year":"2012","unstructured":"Sigismund, S. et al. Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol. Rev. 92, 273\u2013366 (2012).","journal-title":"Physiol. Rev."},{"key":"48836_CR24","doi-asserted-by":"publisher","first-page":"15094","DOI":"10.1074\/jbc.M117.790139","volume":"292","author":"M Aarnio-Peterson","year":"2017","unstructured":"Aarnio-Peterson, M. et al. Altered Met receptor phosphorylation and LRP1-mediated uptake in cells lacking carbohydrate-dependent lysosomal targeting. J. Biol. Chem. 292, 15094\u201315104 (2017).","journal-title":"J. Biol. Chem."},{"key":"48836_CR25","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fcell.2020.00490","volume":"8","author":"X Hu","year":"2020","unstructured":"Hu, X. et al. Structural and functional insight into the glycosylation impact upon the HGF\/c-Met signaling pathway. Front. Cell Dev. Biol. 8, 490 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"48836_CR26","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.cell.2005.09.041","volume":"123","author":"K Ohtsubo","year":"2005","unstructured":"Ohtsubo, K. et al. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123, 1307\u20131321 (2005).","journal-title":"Cell"},{"key":"48836_CR27","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.3390\/ijms26189228","volume":"26","author":"S Ji","year":"2025","unstructured":"Ji, S. et al. Inhibitory effect of fucoidan analogs on highly metastatic gastric cancer cells via galectin-4 inhibition. Int. J. Mol. Sci. 26, 9228 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"48836_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","volume":"7","author":"Z-N Lei","year":"2022","unstructured":"Lei, Z.-N. et al. Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduct. Target Ther. 7, 358 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"48836_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s13046-022-02515-x","volume":"41","author":"L Gandullo-S\u00e1nchez","year":"2022","unstructured":"Gandullo-S\u00e1nchez, L., Oca\u00f1a, A. & Pandiella, A. HER3 in cancer: From the bench to the bedside. J. Exp. Clin. Cancer Res. 41, 310 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"48836_CR30","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1158\/1078-0432.CCR-21-3359","volume":"28","author":"K Yonesaka","year":"2022","unstructured":"Yonesaka, K. et al. HER3 augmentation via blockade of EGFR\/AKT signaling enhances anticancer activity of HER3-targeting Patritumab Deruxtecan in EGFR-mutated non-small cell lung cancer. Clin. Cancer Res. 28, 390\u2013403 (2022).","journal-title":"Clin. Cancer Res."},{"key":"48836_CR31","doi-asserted-by":"publisher","first-page":"7843","DOI":"10.1158\/1078-0432.CCR-08-1064","volume":"14","author":"M Hayashi","year":"2008","unstructured":"Hayashi, M. et al. High expression of HER3 is associated with a decreased survival in gastric cancer. Clin. Cancer Res. 14, 7843\u20137849 (2008).","journal-title":"Clin. Cancer Res."},{"key":"48836_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1332057","volume":"14","author":"Q Chen","year":"2023","unstructured":"Chen, Q., Jia, G., Zhang, X. & Ma, W. Targeting HER3 to overcome EGFR TKI resistance in NSCLC. Front. Immunol. 14, 1332057 (2023).","journal-title":"Front. Immunol."},{"key":"48836_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molmed.2018.12.009","volume":"25","author":"AJ Sabnis","year":"2019","unstructured":"Sabnis, A. J. & Bivona, T. G. Principles of resistance to targeted cancer therapy: Lessons from basic and translational cancer biology. Trends Mol. Med. 25, 185\u2013197 (2019).","journal-title":"Trends Mol. Med."},{"issue":"Pt 3","key":"48836_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","volume":"224","author":"S Bolte","year":"2006","unstructured":"Bolte, S. & Cordeli\u00e8res, F. P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224(Pt 3), 213\u2013232 (2006).","journal-title":"J. Microsc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48836-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48836-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48836-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:37:53Z","timestamp":1780875473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48836-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48836"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48836-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17626"}}